Wednesday, October 28, 2020 10:27:42 PM
Very exciting, good stuff.
If they can deliver on things in the works, I'm expecting a triple by the end of next year.
Viral Transport Media (VTM) - should start seeing deliveries in January
QAP's - sales have been increasing, should start seeing those numbers in upcoming quarterly reports. Also, new products being introduced as time goes on.
Antigens - steady business now, gross margins should start increasing beginning with next quarterly
All in all, if they can deliver, revenues should triple for fiscal 2021.
Plus, but a big IF, is Kinlytic Urokinase. They are trying to secure a partner, and once done, 2 1/2 to 3 1/2 years for commercialization and sales, potentially $250M/yr share of the market. Not sure what percentage of that falls to Microbix, but would be substantial.
Recent MBXBF News
- Dually-Listed Biotech Shares Up Big On Tuesday • AllPennyStocks.com • 05/16/2023 08:45:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM